CD117 immunoexpression in canine mast cell tumours: Correlations with pathological variables and proliferation markers

BMC Veterinary Research

Volumn 3, Issue , 2007, Pages

  Da Costa, Rui M Gil ^a   Matos, Eduarda ^a   Rema, Alexandra ^a   Lopes, Célia ^a   Pires, Maria A ^b   Gärtner, Fátima ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; NUCLEAR PROTEIN; NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CELL GROWTH; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; PATHOLOGY; PHYSIOLOGY; SKIN TUMOR; URTICARIA PIGMENTOSA;

ANIMALS; ANTIGENS, NUCLEAR; CELL GROWTH PROCESSES; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MASTOCYTOMA, SKIN; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 67651146857     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-3-19     Document Type: Article

References (36)

1. Goldschmidt MH, Hendrick MJ: Tumours of the skin and soft tissues. In Tumors in domestic animals 4th edition. Edited by: Meuten DJ. Ames: Iowa State Press; 2002:105-107.
2. Liao AT, Chien MB, Shenoy N, Mendel DB, McMahon G, Cherrington JM, London CA: Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 2002, 100:585-593.
3. London CA, Hannh AL, Zadovoskaya R, Chien MB, Kollias-Baker C, Rosenberg M, Downing S, Post G, Boucher J, Shenoy N, Mendel DB, McMahon G, Cherrington JM: Phase I Dose-escalating study of SU1 a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 1654, 9:2755-2768.
4. Pryer NK, Lee LB, Zadovaskaya R, Yu X, Sukbuntherng J, Cherrington JM, London CA: Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. Clin Cancer Res 2003, 9:5729-5734.
5. Patnaik A, Ehler WJ, MacEwen EG: Canine cutaneous mast cell tumor: morphologic grading and survival times in 83 dogs. Vet Pathol 1984, 21:469-474.
6. Hendrick MJ, Mahaffey EA, Moore FM, Vos JH, Walder EJ: Histological classification of mesenchimal tumours of the skin and soft tissues of domestic animals. In WHO classification of tumours of domestic animals Washington DC: AFIP; 1998:28-29.
7. Kiupel M, Webster JD, Miller RA, Kaneene JB: Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. J Vet Med A Physiol Pathol Clin Med 2005, 52:280-286.
8. Abadie JJ, Amardeilh MA, Delverdier ME: Immunohistochemical detection of proliferating cell nuclear antigen and ki67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999, 215:1629-1634.
9. Bostock DE, Crocker J, Herris K, Smith P: Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. Br J Cancer 1989, 59:915-918.
10. Sakai H, Noda A, Shirai N, Iidaka T, Yanai T, Masegi T: Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and ki67 expression. J Comp Pathol 2002, 127:233-238.
11. Simões JP, Schoning P, Butine M: Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 1994, 31:637-647.
12. London CA, Kisseberth WC, Galli SJ, Geissler EN, Helfand SC: Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol 1996, 115:399-414.
13. Morini M, Bettini G, Preziosi R, Mandrioli L: C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. J Histochem Cytochem 2004, 52:705-708.
14. Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L: Canine mast cell tumors express stem cell factor receptor. Am J Dermatopathol 2000, 22:49-54.
15. Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V: The use of KIT and tryptase expression patterns as prognostic tools for canine mast cell tumors. Vet Pathol 2004, 41:371-377.
16. Ronnstrand L: Signal transduction via the stem cell factor receptor/c-kit. Cell Mol Life Sci 2004, 61:2535-2548.
17. Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P: Differential roles of PI3-kinase and kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. The EMBO Journal 1995, 14:473-483.
18. Timokhina I, Kissel H, Stella G, Besmer P: Kit signalling through PI3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J 1998, 17:6250-6262.
19. Vosseller K, Stella G, Yee NS, Besmer P: C-Kit receptor signalling through it's phosphatidylinositide-3'-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion and membrane ruffling. Mo Biol Cell 1997, 8:909-922.
20. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD: A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004, 103:3222-3225.
21. Metcalfe DD, Akin C: Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk Res 2001, 25:577-582.
22. Beghini A, Peterlongo P, Ripamonti CB, Larizza L, Cairoli R, Morra E, Mercucci C: C-kit mutations in core binding factor leukemias. Blood 2000, 95:726-727.
23. Hongyo T, Li T, Syaifudin M, Baskar R, Ikeda H, Kanakura Y, Aozasa K, Nomura T: Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res 2000, 60:2345-2347.
24. Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden J: Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol 2000, 157:1581-1585.
25. Kitamura Y, Hirota S, Nishida T: Gastrointestinal stromal tumors (GIST) : a model for molecule-based diagnosis and treatment of solid tumors. Cancer Sci 2003, 94:315-320.
26. Tian Q, Frierson HF Jr, Krystal GW, Moskaluk CA: Activating c-kit mutations in human germ cell tumors. Am J Pathol 1999, 154:1643-1647.
27. London CA, Galli SJ, Yuuki T, Hu Z-Q, Helfand SC, Geissler EN: Spontaneous canine mast cell tumours express tandem duplication in the proto-oncogene c-KIT. Exp Hematol 1999, 27:689-97.
28. Ma Y, Longley BJ, Wang X, Blount JL, Langley K, Caughey GH: Clustering of activating mutations in c-KIT' s, juxtamembrane coding region in canine mast cell neoplasms. J Invest Dermatol 1999, 112:165-70.
29. Riva F, Brizzola S, Stefanello D, Crema S, Turin L: A study of mutations in the c-kit gene of 32 dogs with mastocytoma. J Vet Diagn Invest 2005, 17:385-388.
30. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: Mutations in the juxtamembrane domain of c-kit are associated with higher grade mast cell tumors in dogs. Veterinary Pathology 2002, 39:529-535.
31. Longley BJ, Reguera MJ, Ma Y: Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leukaemia Research 2001, 25:571-576.
32. Webster JD, Yuzbasyian-Gurkan V, Kaneene JB, Miller R, Resau JH, Kupel M: The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 2006, 8:104-111.
33. Sheu LF, Lee WC, Lee HS, Kao WY, Chen A: Co-expression of ckit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium. J Pathol 2005, 207:216-223.
34. Derenzini M, Ploton D: Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 1991, 32:149-192.
35. Orrell JM, Evans AT, Grant A: A critical evaluation of AgNORs counting in benign naevi and malignant melanoma. J Pathol 1991, 163:239-244.
36. Geraldes M, Gärtner Schmitt F: Hormonal receptors and cell proliferation in normal breast and spontaneous canine mammary tumours: an immunohistochemical study. Vet Rec 2000, 146:403-406.